PATHOGENESIS AND TREATMENT OF EXPERIMENTAL PERITONITIS

实验性腹膜炎的发病机制和治疗

基本信息

项目摘要

Secondary bacterial peritonitis continues to be a difficult problem for both patient and surgeon. Even with the advent of newer antibiotics, little improvement in mortality has been achieved. Within the internal milieu of the peritoneal cavity, host defense mechanisms normally should act to limit the growth and dispersion of invading microorganisms. We seek to obtain a better understanding of these host defenses both at the cellular level as well as in the entire animal. In particular, the aims of this grant are 1) to define the mechanism of the potentiating effect of hemoglobin in experimental peritonitis, 2) to determine the specific action of fibrinogen and fibrin in experimental peritonitis and intraperitoneal abscess formation. In the first case, the present evidence supports the idea that hemoglobin permits certain strains of E. coli to elaborate leukotoxins which inhibit the bacteriocidal function of neutrophils and monocytes. This, in turn, permits the bacteria to proliferate to lethal levels. In the second, fibrin and its breakdown products impair the bacteriocidal function of neutrophils and monocytes by a different mechanism, i.e. by impairing access to the bacteria by limiting the migration of host cells into contact with bacteria. To test these hypotheses, both in vivo and in vitro techniques will be necessary. For the first aim, the basic strategy is to isolate and characterize those products of the interaction between bacteria and hemoglobin which impair neutrophil function in vitro. These materials will then be tested in rats for their capacity to potentiate infections with bacterial strains which cannot be potentiated with hemoglobin itself. For the second aim, we plan to differentiate between the physical entrapment of neutrophils by fibrin, its chemical effects on the neutrophil and its alteration of the physiological milieu.
继发性细菌性腹膜炎仍然是一个难题

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD L. SIMMONS其他文献

Transplantation Experiments on Placental Ageing
胎盘老化的移植实验
  • DOI:
    10.1038/208082b0
  • 发表时间:
    1965-10-01
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    RICHARD L. SIMMONS;JOEL WEINTRAUB
  • 通讯作者:
    JOEL WEINTRAUB
Histocompatibility Antigens in Transplanted Mouse Eggs
  • DOI:
    10.1038/208698a0
  • 发表时间:
    1965-11-13
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    RICHARD L. SIMMONS;PAUL S. RUSSELL
  • 通讯作者:
    PAUL S. RUSSELL

RICHARD L. SIMMONS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD L. SIMMONS', 18)}}的其他基金

iNOS gene therapy to prevent allograft vasculopathy
iNOS 基因治疗预防同种异体移植血管病变
  • 批准号:
    6668348
  • 财政年份:
    2002
  • 资助金额:
    $ 13.88万
  • 项目类别:
iNOS gene therapy to prevent allograft vasculopathy
iNOS 基因治疗预防同种异体移植血管病变
  • 批准号:
    6666446
  • 财政年份:
    2002
  • 资助金额:
    $ 13.88万
  • 项目类别:
iNOS gene therapy to prevent allograft vasculopathy
iNOS 基因治疗预防同种异体移植血管病变
  • 批准号:
    6501576
  • 财政年份:
    2001
  • 资助金额:
    $ 13.88万
  • 项目类别:
iNOS gene therapy to prevent allograft vasculopathy
iNOS 基因治疗预防同种异体移植血管病变
  • 批准号:
    6434100
  • 财政年份:
    2001
  • 资助金额:
    $ 13.88万
  • 项目类别:
EFFECTORS IN THE ALLOGRAFT RESPONSE
同种异体移植反应中的影响因素
  • 批准号:
    6266743
  • 财政年份:
    2001
  • 资助金额:
    $ 13.88万
  • 项目类别:
iNOS gene therapy to prevent allograft vasculopathy
iNOS 基因治疗预防同种异体移植血管病变
  • 批准号:
    6365386
  • 财政年份:
    2000
  • 资助金额:
    $ 13.88万
  • 项目类别:
TRAINING IN TRAUMA AND SEPSIS RESEARCH
创伤和脓毒症研究培训
  • 批准号:
    2168338
  • 财政年份:
    1994
  • 资助金额:
    $ 13.88万
  • 项目类别:
TRAINING IN TRAUMA AND SEPSIS RESEARCH
创伤和脓毒症研究培训
  • 批准号:
    2168339
  • 财政年份:
    1994
  • 资助金额:
    $ 13.88万
  • 项目类别:
TRAINING IN TRAUMA AND SEPSIS RESEARCH
创伤和脓毒症研究培训
  • 批准号:
    2168340
  • 财政年份:
    1994
  • 资助金额:
    $ 13.88万
  • 项目类别:
TRAINING IN TRAUMA AND SEPSIS RESEARCH
创伤和脓毒症研究培训
  • 批准号:
    6351089
  • 财政年份:
    1994
  • 资助金额:
    $ 13.88万
  • 项目类别:

相似海外基金

Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
  • 批准号:
    23K07930
  • 财政年份:
    2023
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
  • 批准号:
    23K07918
  • 财政年份:
    2023
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
  • 批准号:
    472342
  • 财政年份:
    2022
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
  • 批准号:
    22K07406
  • 财政年份:
    2022
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
  • 批准号:
    569719-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
  • 批准号:
    531450-2018
  • 财政年份:
    2022
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
  • 批准号:
    521908-2018
  • 财政年份:
    2021
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
  • 批准号:
    531450-2018
  • 财政年份:
    2021
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
  • 批准号:
    521908-2018
  • 财政年份:
    2020
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
  • 批准号:
    531450-2018
  • 财政年份:
    2020
  • 资助金额:
    $ 13.88万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了